What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Immune system
Her main research concerns Immunology, Cell biology, Immune system, Innate immune system and Inflammation.
Her Immunology research incorporates elements of Autophagy, Cancer research and Skeletal muscle.
Her Cell biology research is multidisciplinary, incorporating perspectives in Platelet activation, Platelet, T cell and HMGB1.
Her Immune system research incorporates themes from Stromal cell and Chemotaxis.
Her Innate immune system study incorporates themes from Cell, PTX3, Complement system and Immunity.
She has researched Inflammation in several fields, including Tumor necrosis factor alpha, Insomnia and Stem cell.
Her most cited work include:
- HMGB1 is an endogenous immune adjuvant released by necrotic cells (513 citations)
- Consensus guidelines for the detection of immunogenic cell death (449 citations)
- Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. (436 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Immunology, Internal medicine, Inflammation, Cell biology and Immune system.
Immunology is closely attributed to Skeletal muscle in her study.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology.
Her Inflammation research includes themes of Tumor necrosis factor alpha and Pathogenesis, Pathology.
Her Cell biology research is multidisciplinary, relying on both Cell, Macrophage, HMGB1 and Antigen.
Her research investigates the link between HMGB1 and topics such as Platelet activation that cross with problems in Integrin.
She most often published in these fields:
- Immunology (42.86%)
- Internal medicine (24.79%)
- Inflammation (21.43%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (24.79%)
- Severe acute respiratory syndrome coronavirus 2 (3.78%)
- Pneumonia (3.78%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Severe acute respiratory syndrome coronavirus 2, Pneumonia, Cohort and Intensive care unit.
Her studies in Internal medicine integrate themes in fields like Gastroenterology and Diabetes mellitus.
Her Pneumonia study also includes fields such as
- Mavrilimumab which connect with Log-rank test, Randomized controlled trial, Clinical course and Adverse effect,
- Survival rate which is related to area like Antigen,
- Blockade, which have a strong connection to Atrophy, Sarcopenia, Tumor necrosis factor alpha and Myocyte.
Patrizia Rovere-Querini works mostly in the field of Cohort, limiting it down to topics relating to Multivariate analysis and, in certain cases, Gestational age, In utero and Neonatal intensive care unit, as a part of the same area of interest.
Her Intensive care unit study integrates concerns from other disciplines, such as Hormone, Neuroradiology, Disease and Testosterone.
Patrizia Rovere-Querini performs multidisciplinary study in the fields of Blocking and Immunology via her papers.
Between 2018 and 2021, her most popular works were:
- Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. (436 citations)
- Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis (186 citations)
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. (183 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
Patrizia Rovere-Querini mainly focuses on Internal medicine, Mechanical ventilation, Disease, Retrospective cohort study and Emergency department.
Her studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Survival analysis.
Her research integrates issues of Coronary artery disease, Acute respiratory distress, Lung and Pulmonary thrombosis in her study of Disease.
Her Retrospective cohort study study combines topics in areas such as Pregnancy, Antiphospholipid syndrome, Intensive care and Standard treatment.
Her Intensive care research includes elements of Respiratory function and Anakinra.
Her work in Cohort addresses issues such as Survival rate, which are connected to fields such as Cohort study, Antibody and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
